LOAMU
CELU icon

Lombard Odier Asset Management (USA)’s Celularity CELU Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-8,492
Closed -$49K – 398
2022
Q2 		$49K Buy
+8,492
New +$690K ﹤0.01% 311

Other funds holding CELU

SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
CVSC
C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LDFO
Louis-Dreyfus Family Office Wilton, Connecticut $64.7M AUM 21.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s CELU Position: Q2 2022 in Review

Lombard Odier Asset Management (USA) sold out of Celularity (CELU) in Q2 2022, closing a stake of 5,000 shares — an estimated $406K sold.

Lombard Odier Asset Management (USA) first reported a position in CELU in Q1 2021 and held it in 4 quarters. The position peaked at $4.03M in Q1 2021. 66 funds tracked by Wall St. Rank hold CELU as of Q2 2022.

  • Lombard Odier Asset Management (USA) reported no remaining Celularity position as of Q2 2022 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 5,000 Celularity shares in Q2 2022, an estimated $406K.
  • Lombard Odier Asset Management (USA) first reported a position in Celularity in Q1 2021 and held it in 4 quarters.
  • Lombard Odier Asset Management (USA)'s Celularity position peaked at $4.03M in Q1 2021.
  • 66 funds tracked by Wall St. Rank held Celularity as of Q2 2022.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q2 2022, filed 15 Aug 2022.